Catalog11 refs
Vilon
BioregulatorsImmune ModulationTissue-specific immune system peptidePreclinical BioregulatorsResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
epithelial cells
Overview
A Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it acts as a molecular signaling compound that restores normal gene expression and protein synthesis in immune and epithelial cells through epigenetic modulation.
Primary Uses
Gene-expression modulation
Immune and hematopoietic support
Aging biology
Cell differentiation studies
Thymus rejuvenation
T-cell activation
Age-related immune decline
Lifespan extension
Tumor suppression
Tissue regeneration from radiation damage
Intestinal function restoration
Intestinal barrier function enhancement
Immune system research
Immune system support
Modulate gene expression in thymus and immune cells
Influence T-cell function and development
Protocol Reference
Dose
2 mg
Frequency
Daily
Half-life
Short (dipeptide)
Route
Injection
Evidence
Preclinical / Moderate Research (disputed)
Research References· 15
Research Models
HumanMouseRatrodents
Also in Bioregulators